AgeX Therapeutics is a company focused on the development and commercialization of therapeutics targeting human aging. Its PureStem technology enables generation of pluripotent stem cell-derived young cells for potential application in treatment of degenerative diseases of aging. The company also provides iTR, a platform aimed at increasing cellular regenerative capacity.